Financial Snapshot
Revenues
Revenues
Revenue YoY Change
Revenues
Concept | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $1.125B | $1.128B | $1.087B | $943.4M | $963.0M | $975.8M | $1.041B | $882.1M | $806.2M | $713.5M | $595.6M | $616.9M | $441.1M | $336.5M | $292.6M | $294.3M | $306.6M | $296.0M | $296.7M | $289.1M | $85.30M | $71.70M | $46.20M |
YoY Change | -0.21% | 3.76% | 15.21% | -2.04% | -1.31% | -6.28% | 18.04% | 9.4% | 13.01% | 19.78% | -3.45% | 39.86% | 31.08% | 15.01% | -0.58% | -4.01% | 3.58% | -0.24% | 2.63% | 238.92% | 18.97% | 55.19% |
Expenses
Cost Of Revenues
Gross Profit
Gross Profit Margin
Gross Profit
Concept | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $1.125B | $1.128B | $1.087B | $943.4M | $963.0M | $975.8M | $1.041B | $882.1M | $806.2M | $713.5M | $595.6M | $616.9M | $441.1M | $336.5M | $292.6M | $294.3M | $306.6M | $296.0M | $296.7M | $289.1M | $85.30M | $71.70M | $46.20M |
Cost Of Revenue | $500.9M | $502.4M | $466.2M | $395.9M | $410.8M | $420.2M | $464.7M | $381.8M | $339.0M | $308.4M | $261.8M | $276.4M | $213.7M | $165.6M | $139.2M | $138.9M | $146.0M | $139.9M | $139.4M | $139.0M | $36.20M | $27.00M | $18.70M |
Gross Profit | $624.4M | $625.3M | $620.6M | $547.5M | $552.2M | $555.6M | $576.5M | $500.3M | $467.2M | $406.2M | $335.6M | $343.7M | $227.4M | $170.9M | $153.4M | $155.4M | $160.6M | $156.1M | $157.2M | $150.1M | $49.10M | $44.70M | $27.50M |
Gross Profit Margin | 55.49% | 55.45% | 57.11% | 58.03% | 57.34% | 56.94% | 55.37% | 56.72% | 57.95% | 56.94% | 56.33% | 55.72% | 51.55% | 50.78% | 52.44% | 52.8% | 52.38% | 52.74% | 52.98% | 51.92% | 57.56% | 62.34% | 59.52% |
Selling, General & Admin Expense
Research & Development
Depreciation, Depletion & Amortization
SGA Expense to Gross Profit Ratio
R&D To Gross Profit Ratio
DDA To Gross Profit Ratio
Operating Expenses Total
Operating Profits/Loss
Operating Profits/Loss YoY Change
Operating Earnings to Gross Profit Ratio
Operating Profit Margin
Operational Expenses
Concept | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General & Admin | $259.5M | $252.4M | $265.9M | $226.1M | $236.3M | $227.8M | $230.0M | $201.5M | $180.8M | $179.2M | $133.4M | $142.1M | $113.8M | $84.90M | $65.10M | $69.30M | $65.10M | $59.40M | $53.20M | $49.90M | $25.00M | $23.20M | $13.80M |
YoY Change | 2.79% | -5.06% | 17.58% | -4.32% | 3.73% | -0.96% | 14.14% | 11.45% | 0.89% | 34.33% | -6.12% | 24.87% | 34.04% | 30.41% | -6.06% | 6.45% | 9.6% | 11.65% | 6.61% | 99.6% | 7.76% | 68.12% | |
% of Gross Profit | 41.55% | 40.37% | 42.84% | 41.3% | 42.79% | 41.0% | 39.9% | 40.28% | 38.7% | 44.11% | 39.76% | 41.34% | 50.05% | 49.68% | 42.43% | 44.59% | 40.54% | 38.05% | 33.84% | 33.24% | 50.92% | 51.9% | 50.18% |
Research & Development | |||||||||||||||||||||||
YoY Change | |||||||||||||||||||||||
% of Gross Profit | |||||||||||||||||||||||
Depreciation & Amortization | $30.68M | $32.63M | $32.09M | $30.16M | $29.00M | $31.78M | $33.43M | $25.79M | $23.68M | $17.74M | $13.49M | $13.24M | $10.73M | $10.11M | $11.45M | $11.20M | $11.00M | $10.40M | $10.80M | $9.800M | $5.400M | $5.300M | $5.500M |
YoY Change | -5.98% | 1.66% | 6.39% | 4.03% | -8.76% | -4.93% | 29.6% | 8.94% | 33.46% | 31.54% | 1.9% | 23.3% | 6.19% | -11.72% | 2.23% | 1.82% | 5.77% | -3.7% | 10.2% | 81.48% | 1.89% | -3.64% | |
% of Gross Profit | 4.91% | 5.22% | 5.17% | 5.51% | 5.25% | 5.72% | 5.8% | 5.16% | 5.07% | 4.37% | 4.02% | 3.85% | 4.72% | 5.92% | 7.46% | 7.21% | 6.85% | 6.66% | 6.87% | 6.53% | 11.0% | 11.86% | 20.0% |
Operating Expenses | $282.0M | $647.7M | $290.7M | $250.1M | $261.1M | $488.1M | $361.0M | $294.6M | $206.9M | $198.7M | $146.9M | $151.9M | $124.6M | $94.73M | $75.12M | $78.10M | $73.60M | $67.50M | $64.10M | $59.70M | $30.50M | $28.50M | $17.80M |
YoY Change | -56.46% | 122.79% | 16.26% | -4.21% | -46.51% | 35.19% | 22.53% | 42.41% | 4.14% | 35.21% | -3.24% | 21.91% | 31.49% | 26.11% | -3.82% | 6.11% | 9.04% | 5.3% | 7.37% | 95.74% | 7.02% | 60.11% | |
Operating Profit | $342.4M | -$22.42M | $329.9M | $297.4M | $291.2M | $67.50M | $215.5M | $205.6M | $260.3M | $207.6M | $188.6M | $191.9M | $102.8M | $76.15M | $78.33M | $77.30M | $87.00M | $88.60M | $93.10M | $90.40M | $18.60M | $16.20M | $9.700M |
YoY Change | -1627.68% | -106.79% | 10.93% | 2.15% | 331.32% | -68.67% | 4.78% | -21.0% | 25.42% | 10.04% | -1.7% | 86.62% | 35.04% | -2.78% | 1.33% | -11.15% | -1.81% | -4.83% | 2.99% | 386.02% | 14.81% | 67.01% | |
Operating Profit To Gross Profit | 54.84% | -3.58% | 53.16% | 54.32% | 52.72% | 12.15% | 37.38% | 41.11% | 55.72% | 51.09% | 56.21% | 55.82% | 45.22% | 44.56% | 51.04% | 49.74% | 54.17% | 56.76% | 59.22% | 60.23% | 37.88% | 36.24% | 35.27% |
Operating Profit To Revenue | 30.43% | -1.99% | 30.36% | 31.53% | 30.23% | 6.92% | 20.7% | 23.31% | 32.29% | 29.09% | 31.67% | 31.1% | 23.31% | 22.63% | 26.77% | 26.27% | 28.38% | 29.93% | 31.38% | 31.27% | 21.81% | 22.59% | 21.0% |
Interest Expenses
Interest Expenses To Operating Income %
Other Expense/Income
Interest & Other Expense/Income
Concept | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Interest Expense | $5.200M | -$69.16M | -$64.29M | -$82.30M | -$96.20M | -$105.1M | -$105.9M | -$93.30M | -$85.20M | -$81.20M | -$68.60M | -$84.40M | -$41.30M | -$27.30M | -$22.90M | -$28.40M | -$37.40M | -$39.50M | -$36.30M | -$44.70M | -$9.900M | -$9.700M | -$8.800M |
YoY Change | -107.52% | 7.59% | -21.89% | -14.45% | -8.47% | -0.76% | 13.5% | 9.51% | 4.93% | 18.37% | -18.72% | 104.36% | 51.28% | 19.21% | -19.37% | -24.06% | -5.32% | 8.82% | -18.79% | 351.52% | 2.06% | 10.23% | |
% of Operating Profit | 1.52% | -19.49% | -27.67% | -33.04% | -155.7% | -49.15% | -45.37% | -32.73% | -39.12% | -36.37% | -43.98% | -40.17% | -35.85% | -29.24% | -36.74% | -42.99% | -44.58% | -38.99% | -49.45% | -53.23% | -59.88% | -90.72% | |
Other Income/Expense, Net | $756.0K | -$2.336M | -$1.052M | $1.366M | -$1.625M | -$476.0K | $392.0K | -$30.00K | $0.00 | $0.00 | $0.00 | ||||||||||||
YoY Change | -132.36% | 122.05% | -177.01% | -184.06% | 241.39% | -221.43% | -1406.67% |
Income/Loss
Pretax Income
Income Tax
Net Profits/Loss
Pretax Income YoY Change
Income Tax Rate
Net Profits/Loss YoY Change
Basic EPS
Net Income To Revenue Ratio
Pretax & Net Income
Concept | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pretax Income | $276.0M | -$93.92M | $262.5M | $204.1M | $191.2M | -$38.06M | $107.1M | $110.9M | $157.2M | $127.5M | $101.7M | $106.0M | $61.16M | $48.53M | $52.73M | -$200.4M | $49.60M | $49.20M | $47.60M | $18.80M | $7.300M | $5.800M | $900.0K |
YoY Change | -393.91% | -135.78% | 28.58% | 6.78% | -602.3% | -135.54% | -3.4% | -29.48% | 23.32% | 25.27% | -4.04% | 73.38% | 26.02% | -7.98% | -126.31% | -504.03% | 0.81% | 3.36% | 153.19% | 157.53% | 25.86% | 544.44% | |
Income Tax | $66.69M | -$11.61M | $57.08M | $39.43M | $48.87M | -$2.255M | -$232.5M | $41.46M | $57.28M | $49.20M | $29.13M | $40.53M | $23.95M | $19.35M | $20.66M | -$10.90M | $18.60M | $17.00M | $21.30M | $8.600M | $2.900M | $3.300M | $300.0K |
% Of Pretax Income | 24.16% | 21.75% | 19.32% | 25.57% | -217.1% | 37.4% | 36.44% | 38.6% | 28.63% | 38.22% | 39.15% | 39.87% | 39.19% | 37.5% | 34.55% | 44.75% | 45.74% | 39.73% | 56.9% | 33.33% | |||
Net Earnings | $209.3M | -$82.31M | $205.4M | $164.7M | $142.3M | -$35.80M | $339.6M | $69.40M | $99.91M | $78.26M | $72.62M | $65.51M | $37.21M | $29.22M | $32.12M | -$186.8M | $33.90M | $36.10M | $26.30M | $10.20M | $4.400M | -$14.90M | $600.0K |
YoY Change | -354.34% | -140.07% | 24.71% | 15.74% | -497.43% | -110.54% | 389.33% | -30.54% | 27.66% | 7.77% | 10.85% | 76.03% | 27.35% | -9.01% | -117.19% | -651.03% | -6.09% | 37.26% | 157.84% | 131.82% | -129.53% | -2583.33% | |
Net Earnings / Revenue | 18.6% | -7.3% | 18.9% | 17.46% | 14.77% | -3.67% | 32.61% | 7.87% | 12.39% | 10.97% | 12.19% | 10.62% | 8.44% | 8.68% | 10.98% | -63.47% | 11.06% | 12.2% | 8.86% | 3.53% | 5.16% | -20.78% | 1.3% |
Basic Earnings Per Share | $4.21 | -$1.65 | $4.09 | $3.28 | $2.81 | -$0.69 | $6.40 | $1.31 | $1.89 | $1.50 | $1.41 | $1.29 | $0.74 | $0.58 | $0.64 | ||||||||
Diluted Earnings Per Share | $4.17 | -$1.65 | $4.04 | $3.25 | $2.78 | -$0.69 | $6.34 | $1.30 | $1.88 | $1.49 | $1.39 | $1.27 | $0.73 | $0.58 | $0.64 | -$3.743M | $678.0K | $722.0K | $526.0K | $370.9K | $165.4K | -$298.0K | $12.00K |
Assets & Liabilities
Cash & Short-Term Investments
Cash & Equivalents
Cash To Operating Expenses Ratio
Inventory
Receivables
Total Short-Term Assets
Property, Plant And Equipment
Long-Term Investments
Total Long-Term Assets
Total Assets
Net Income To Total Assets Percentage
Accounts Payable
Short-Term Debt
Long Term Debt Due
Total Short-Term Liabilities
Long-Term Debt
Other Long-Term Liabilities
Total Long-Term Liabilities
Total Liabilities
Short-Term To Long-Term Debt Ratio
Short-Term Assets To Debt Ratio
Long-Term Debt To Net Income Ratio
Assets & Liabilities
Concept | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Short-Term Investments | $46.47M | $58.49M | $27.19M | $32.30M | $94.80M | $27.50M | $32.50M | $41.90M | $27.20M | $21.30M | $28.30M | $15.70M | $19.00M | $13.30M | $41.10M | $35.20M | $6.100M | $13.80M | $8.200M | $5.300M | $3.400M | $3.500M | |
YoY Change | -20.55% | 115.15% | -15.84% | -65.93% | 244.73% | -15.38% | -22.43% | 54.04% | 27.7% | -24.73% | 80.25% | -17.37% | 42.86% | -67.64% | 16.76% | 477.05% | -55.8% | 68.29% | 54.72% | 55.88% | -2.86% | ||
Cash & Equivalents | $46.47M | $58.49M | $27.19M | $32.30M | $94.80M | $27.50M | $32.50M | $41.90M | $27.20M | $21.30M | $28.30M | $15.70M | $19.00M | $13.30M | $41.10M | $35.20M | $6.100M | $13.80M | $8.200M | $5.300M | $3.400M | $3.500M | |
Short-Term Investments | |||||||||||||||||||||||
Other Short-Term Assets | $13.08M | $4.117M | $6.410M | $7.900M | $4.400M | $4.700M | $11.50M | $40.20M | $35.30M | $18.50M | $18.20M | $15.20M | $16.70M | $10.10M | $12.70M | $6.500M | $5.400M | $4.600M | $3.900M | $8.900M | $1.800M | $1.300M | |
YoY Change | 217.76% | -35.77% | -18.86% | 79.55% | -6.38% | -59.13% | -71.39% | 13.88% | 90.81% | 1.65% | 19.74% | -8.98% | 65.35% | -20.47% | 95.38% | 20.37% | 17.39% | 17.95% | -56.18% | 394.44% | 38.46% | ||
Inventory | $138.7M | $162.1M | $120.3M | $115.0M | $116.0M | $119.9M | $118.5M | $115.6M | $91.30M | $74.00M | $65.60M | $60.20M | $51.10M | $39.80M | $27.70M | $25.90M | $29.70M | $30.20M | $33.80M | $24.80M | $10.70M | $5.600M | |
Prepaid Expenses | |||||||||||||||||||||||
Receivables | $176.8M | $167.0M | $139.3M | $114.6M | $150.0M | $148.1M | $140.1M | $135.3M | $94.00M | $85.50M | $65.10M | $72.40M | $50.90M | $43.70M | $29.00M | $34.90M | $42.80M | $33.50M | $38.20M | $35.10M | $13.00M | $13.00M | |
Other Receivables | $0.00 | $0.00 | $0.00 | $100.0K | $500.0K | $700.0K | $800.0K | $1.400M | $1.200M | $2.400M | $0.00 | $700.0K | $9.300M | $700.0K | $1.600M | $1.100M | $1.400M | $1.700M | $1.800M | $800.0K | $400.0K | $200.0K | |
Total Short-Term Assets | $375.0M | $391.7M | $293.3M | $269.8M | $365.7M | $300.9M | $303.5M | $334.4M | $249.0M | $201.7M | $177.2M | $164.2M | $147.0M | $107.6M | $112.2M | $103.6M | $85.40M | $83.80M | $86.00M | $74.90M | $29.30M | $23.60M | |
YoY Change | -4.26% | 33.58% | 8.7% | -26.22% | 21.54% | -0.86% | -9.24% | 34.3% | 23.45% | 13.83% | 7.92% | 11.7% | 36.62% | -4.1% | 8.3% | 21.31% | 1.91% | -2.56% | 14.82% | 155.63% | 24.15% | ||
Property, Plant & Equipment | $89.33M | $89.54M | $98.53M | $102.8M | $90.70M | $51.20M | $52.60M | $50.60M | $15.50M | $13.70M | $9.600M | $9.900M | $1.300M | $1.400M | $1.400M | $1.400M | $1.400M | $1.400M | $1.700M | $2.300M | $900.0K | $600.0K | |
YoY Change | -0.23% | -9.13% | -4.15% | 13.34% | 77.15% | -2.66% | 3.95% | 226.45% | 13.14% | 42.71% | -3.03% | 661.54% | -7.14% | 0.0% | 0.0% | 0.0% | 0.0% | -17.65% | -26.09% | 155.56% | 50.0% | ||
Goodwill | |||||||||||||||||||||||
YoY Change | |||||||||||||||||||||||
Intangibles | |||||||||||||||||||||||
YoY Change | |||||||||||||||||||||||
Long-Term Investments | |||||||||||||||||||||||
YoY Change | |||||||||||||||||||||||
Other Assets | $5.725M | $3.005M | $3.273M | $2.900M | $3.000M | $3.100M | $3.600M | $7.500M | $1.300M | $1.200M | $23.20M | $24.90M | $35.70M | $6.600M | $12.00M | $13.10M | $6.800M | $10.10M | $15.80M | $16.00M | $2.800M | $5.200M | |
YoY Change | 90.52% | -8.19% | 12.86% | -3.33% | -3.23% | -13.89% | -52.0% | 476.92% | 8.33% | -94.83% | -6.83% | -30.25% | 440.91% | -45.0% | -8.4% | 92.65% | -32.67% | -36.08% | -1.25% | 471.43% | -46.15% | ||
Total Long-Term Assets | $2.943B | $2.962B | $3.377B | $3.160B | $3.148B | $3.140B | $3.457B | $3.577B | $2.700B | $2.440B | $1.619B | $1.576B | $1.611B | $949.3M | $679.2M | $697.8M | $963.8M | $979.6M | $952.6M | $921.7M | $296.1M | $120.3M | |
YoY Change | -0.63% | -12.3% | 6.9% | 0.36% | 0.26% | -9.17% | -3.35% | 32.49% | 10.63% | 50.78% | 2.72% | -2.22% | 69.74% | 39.77% | -2.67% | -27.6% | -1.61% | 2.83% | 3.35% | 211.28% | 146.13% | ||
Total Assets | $3.318B | $3.354B | $3.671B | $3.429B | $3.514B | $3.441B | $3.761B | $3.911B | $2.949B | $2.642B | $1.796B | $1.740B | $1.758B | $1.057B | $791.4M | $801.4M | $1.049B | $1.063B | $1.039B | $996.6M | $325.4M | $143.9M | |
YoY Change | |||||||||||||||||||||||
Accounts Payable | $38.98M | $62.74M | $55.76M | $46.00M | $62.40M | $56.60M | $61.40M | $70.20M | $38.30M | $46.10M | $48.30M | $51.40M | $26.70M | $21.60M | $12.80M | $15.90M | $20.50M | $19.30M | $18.10M | $21.70M | $5.300M | $4.400M | |
YoY Change | -37.88% | 12.52% | 21.22% | -26.28% | 10.25% | -7.82% | -12.54% | 83.29% | -16.92% | -4.55% | -6.03% | 92.51% | 23.61% | 68.75% | -19.5% | -22.44% | 6.22% | 6.63% | -16.59% | 309.43% | 20.45% | ||
Accrued Expenses | $74.01M | $84.49M | $82.24M | $71.90M | $81.20M | $70.30M | $59.90M | $69.00M | $58.40M | $50.30M | $34.20M | $44.80M | $36.60M | $32.10M | $13.30M | $14.10M | $13.80M | $18.10M | $12.10M | $11.60M | $6.600M | $9.100M | |
YoY Change | -12.41% | 2.74% | 14.38% | -11.45% | 15.5% | 17.36% | -13.19% | 18.15% | 16.1% | 47.08% | -23.66% | 22.4% | 14.02% | 141.35% | -5.67% | 2.17% | -23.76% | 49.59% | 4.31% | 75.76% | -27.47% | ||
Deferred Revenue | |||||||||||||||||||||||
YoY Change | |||||||||||||||||||||||
Short-Term Debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
YoY Change | |||||||||||||||||||||||
Long-Term Debt Due | $1.494M | $2.834M | $2.752M | $2.600M | $1.200M | $0.00 | $29.60M | $3.600M | $3.600M | $3.600M | $3.700M | $3.700M | $2.000M | $19.60M | |||||||||
YoY Change | -47.28% | 2.98% | 5.85% | 116.67% | -100.0% | 722.22% | 0.0% | 0.0% | -2.7% | 0.0% | 85.0% | -89.8% | |||||||||||
Total Short-Term Liabilities | $117.0M | $160.7M | $143.4M | $122.1M | $149.9M | $127.0M | $123.2M | $162.0M | $106.7M | $99.00M | $84.40M | $96.70M | $63.90M | $54.20M | $55.70M | $34.20M | $37.90M | $40.90M | $35.70M | $37.00M | $13.80M | $33.10M | |
YoY Change | -27.17% | 12.06% | 17.46% | -18.55% | 18.03% | 3.08% | -23.95% | 51.83% | 7.78% | 17.3% | -12.72% | 51.33% | 17.9% | -2.69% | 62.87% | -9.76% | -7.33% | 14.57% | -3.51% | 168.12% | -58.31% | ||
Long-Term Debt | $1.126B | $1.347B | $1.481B | $1.487B | $1.735B | $1.799B | $1.993B | $2.194B | $1.625B | $1.561B | $934.4M | $970.9M | $1.124B | $486.9M | $294.6M | $374.8M | $407.7M | $459.8M | $494.9M | $491.6M | $146.7M | $61.40M | |
YoY Change | -16.44% | -9.03% | -0.36% | -14.32% | -3.54% | -9.75% | -9.15% | 34.97% | 4.1% | 67.09% | -3.76% | -13.61% | 130.83% | 65.27% | -21.4% | -8.07% | -11.33% | -7.09% | 0.67% | 235.11% | 138.93% | ||
Other Long-Term Liabilities | $16.71M | $18.04M | $23.57M | $28.30M | $50.30M | $20.10M | $23.30M | $18.00M | $2.800M | $2.500M | $300.0K | $2.400M | $2.800M | $0.00 | $800.0K | ||||||||
YoY Change | -7.36% | -23.46% | -16.71% | -43.74% | 150.25% | -13.73% | 29.44% | 542.86% | 12.0% | 733.33% | -14.29% | ||||||||||||
Total Long-Term Liabilities | $1.143B | $1.365B | $1.505B | $1.515B | $1.785B | $1.819B | $2.016B | $2.212B | $1.628B | $1.564B | $934.7M | $970.9M | $1.124B | $486.9M | $294.6M | $374.8M | $410.1M | $462.6M | $494.9M | $491.6M | $146.7M | $62.20M | |
YoY Change | -16.32% | -9.25% | -0.66% | -15.15% | -1.84% | -9.8% | -8.83% | 35.85% | 4.11% | 67.31% | -3.73% | -13.61% | 130.83% | 65.27% | -21.4% | -8.61% | -11.35% | -6.53% | 0.67% | 235.11% | 135.85% | ||
Total Liabilities | $1.663B | $1.907B | $2.093B | $2.071B | $2.343B | $2.345B | $2.582B | $3.089B | $2.205B | $2.014B | $1.232B | $1.262B | $1.356B | $695.1M | $462.4M | $507.0M | $570.1M | $618.1M | $629.2M | $614.6M | $199.4M | $99.10M | |
YoY Change | -12.76% | -8.91% | 1.07% | -11.61% | -0.1% | -9.17% | -16.41% | 40.11% | 9.44% | 63.46% | -2.35% | -6.91% | 95.01% | 50.32% | -8.8% | -11.07% | -7.77% | -1.76% | 2.38% | 208.22% | 101.21% |
Ownership
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares
Stock Issuance & Repurchase
Ownership Data
Concept | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Basic Shares Outstanding | 49.76M shares | 49.89M shares | 50.26M shares | 50.21M shares | 50.72M shares | 52.07M shares | 53.10M shares | 52.98M shares | 52.75M shares | 52.17M shares | 51.64M shares | 50.63M shares | 50.27M shares | 50.08M shares | 50.01M shares | ||||||||
Diluted Shares Outstanding | 50.18M shares | 49.89M shares | 50.84M shares | 50.61M shares | 51.14M shares | 52.07M shares | 53.53M shares | 53.36M shares | 53.14M shares | 52.67M shares | 52.35M shares | 51.44M shares | 50.75M shares | 50.34M shares | 50.09M shares | ||||||||
Preferred Stock | |||||||||||||||||||||||
Treasury Stock Shares |
Return On Shareholders' Equity
Book Value
Free Cash Flow
Free Cash Flow YoY
Free Cash Flow Margin
Dividends
Dividends
Stock Price
About Prestige Consumer Healthcare Inc
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. The company is headquartered in Tarrytown, New York and currently employs 570 full-time employees. The company went IPO on 2005-02-10. The firm is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores in North America (the United States and Canada) and in Australia and certain other international markets. The company operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
Industry: Pharmaceutical Preparations Peers: Arvinas Inc Pacira Biosciences Inc Corcept Therapeutics Inc Elanco Animal Health Inc Harmony Biosciences Holdings Inc Intra-Cellular Therapies Inc Johnson & Johnson